Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.03 +0.49 (+1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 3
Source: SEC/Edgar
September 10, 2018
Form 4
Source: SEC/Edgar
September 10, 2018
Form 4
Source: SEC/Edgar
August 27, 2018
Form 4
Source: SEC/Edgar
August 22, 2018
Form 4
Source: SEC/Edgar
August 15, 2018
Form 4
Source: SEC/Edgar
August 09, 2018
Form 4
Source: SEC/Edgar
August 05, 2018
Form 4
Source: SEC/Edgar
July 26, 2018
Form 4
Source: SEC/Edgar
June 28, 2018
Form 4
Source: SEC/Edgar
June 17, 2018
Form 4
Source: SEC/Edgar
June 04, 2018
Form 3
Source: SEC/Edgar
May 06, 2018
Form 4
Source: SEC/Edgar
May 01, 2018
Form 4
Source: SEC/Edgar
May 01, 2018
Form 4
Source: SEC/Edgar
May 01, 2018
Form 4
Source: SEC/Edgar
May 01, 2018
Form 4
Source: SEC/Edgar
May 01, 2018
Form 4
Source: SEC/Edgar
May 01, 2018
Form 4
Source: SEC/Edgar
April 12, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 05, 2018
Form 4
Source: SEC/Edgar
February 04, 2018
Form 4
Source: SEC/Edgar
February 04, 2018
Form 4
Source: SEC/Edgar
February 04, 2018
Form 4
Source: SEC/Edgar
January 08, 2018
Form 4
Source: SEC/Edgar
September 20, 2017
Form 4
Source: SEC/Edgar
July 25, 2017
Form 4
Source: SEC/Edgar
May 14, 2017
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.